Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products-Reference-Cited by-同舟云学术

Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products

Published:2009-02 Issue:2 Volume:31 Page:370-385
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Daley-Yates Peter T.,Parkins David A.,Thomas Marian J.,Gillett Benjamin,House Karen W.,Ortega Hector G.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. The Diskus: A review of its position among dry powder inhaler devices;Chrystyn;Int J Clin Pract,2007

2. Dry powder inhalers (DPIs)—a review of device reliability and innovation;Islam;Int J Pharm,2008

3. Therapeutic equivalence of inhaled corticosteroids—Workshop on regional differences in regulatory requirements;Fuglsang;Respiratory Drug Delivery,2008

4. Can we move toward harmonized requirements for bioequivalence of inhalers?;Byron;Respiratory Drug Delivery Europe,2007

5. In vitro bioequivalence of particle size distributions: A commentary on FDA's draft guidance;Byron;Respiratory Drug Delivery VIII,2002

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Bioequivalence between Generic and Originator Orally Inhaled Drug Products: Validity of Administration of Doses above the Approved Single Maximum Dose;Molecular Pharmaceutics;2024-08-12

2. Bioequivalence of Two Tiotropium Dry Powder Inhalers and the Utility of Realistic Impactor Testing;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2023-10-01

3. Managing moderate-to-severe paediatric asthma: a scoping review of the efficacy and safety of fluticasone propionate/salmeterol;BMJ Open Respiratory Research;2023-08

4. Generic dry powder inhalers bioequivalence: Batch–to-batch variability insights;Drug Discovery Today;2022-11

5. In vitro-in vivo correlation of cascade impactor data for orally inhaled pharmaceutical aerosols;Advanced Drug Delivery Reviews;2021-10